Please provide your email address to receive an email when new articles are posted on . This analysis spanned from 2016 to 2022. Nearly 50% of patients were initially prescribed LABA/inhaled ...
There was a notable gap in effectiveness between metered-dose and dry-powder formulations of single-inhaler triple therapy for chronic obstructive pulmonary disease (COPD), according to real-world ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Inhaled corticosteroids are often used outside of the ...
A new inhaler that treats chronic obstructive pulmonary disease (COPD) and also helps reduce environmental harm has been approved for use in the UK. This inhaler is already available in India.
The Medicines and Healthcare products Regulatory Agency (MHRA) has approved the world’s first low-carbon version of a triple-combination inhaler for chronic obstructive pulmonary disease (COPD). The ...
New packaging line doubles Ritedose's capacity to package single, individually wrapped vial medications. The new Syntegon line will support Ritedose's ongoing manufacturing commitment for Verona ...
Digital inhalers may help predict impending acute exacerbations of chronic obstructive pulmonary disease (COPD), according to a new study. The study is published in the May 2025 issue of Chronic ...
A new study finds that a sensor-equipped "smart inhaler" can accurately track how—and how well—COPD patients use their medication at home, offering clinicians real-time insights into patient behavior ...
The 2025 Global Initiative for Chronic Obstructive Lung Disease (GOLD) report highlighted climate change, cardiovascular risk, and pulmonary hypertension. Claus F. Vogelmeier, MD, chair of the GOLD ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback